No. 商品名・サービス名

1 スパイラルアレイ

2 スパイラルアレイ

3 スパイラルアレイ

4 スパイラルアレイ

5 スパイラルアレイ

6 スパイラルアレイ

7 TMA

8 TMA

9 TMA

論文名
Spiral array: a new high-throughput technology covers tissueheterogeneity.
Junya Fukuoka et.al.
Arch Pathol Lab Med 2012 Nov;136(11):1377-84.
DOI: 10.5858/arpa.2011-0393-OA
Application of a new technique, spiral tissue microarrays
constructed using needle biopsy specimens, to prostate cancer
research
Akira Komiya et.al.
Int J Oncol. 2014, 44 (1): 195-202.
DOI:10.3892/ijo.2013.2173
Ki-67 is a strong prognostic marker of non-small cell lung cancer
when tissue heterogeneity is considered
Kazuhiro Tabata et.al.
BMC Clin Pathol. 2014;14: 23.
DOI: 10.1186/1472-6890-14-23
Intratumoral heterogeneity of programmed cell death ligand-1
expression is common in lung cancer.
Sayuri Nakamura et.al.
PLoS One. 2017 Oct 19;12(10)DOI:10.1371/journal.pone.0186192
High Expression Level of Serpin Peptidase InhibitorClade E Member
2 is Associated with PoorPrognosis in Lung Adenocarcinoma.
Ryota Dokuni et.al.

DOI: 10.21203/rs.3.rs-51737/v1
Caspase Recruitment Domain-Containing Protein 9 Expression is a
Novel Prognostic Factor for Lung Adenocarcinoma.
Nanako Miwa et.al.
Onco Targets Ther. 2020 Sep 10;13:9005-9013
DOI:10.2147/OTT.S265539
Discovery of Colorectal Cancer Biomarker Candidates by Membrane
Proteomic Analysis and Subsequent Verification using Selected
Reaction Monitoring (SRM) and Tissue Microarray (TMA) Analysis.
Hideaki Kume et.al.
Molecular & Cellular Proteomics, 2014, 13 (6) 1471-1484]
DOI:10.1074/mcp.M113.037093
The prophylactic effects of a traditional Japanese medicine,
goshajinkigan, on paclitaxel-induced peripheral neuropathy and its
mechanism of action.
Yukiko Matsumura et.al.
Mol Pain 2014 Sep 21;10:61.
DOI:10.1186/1744-8069-10-61
SPARC is a possible predictive marker for albumin-bound paclitaxel
in non-small-cell lung cancer.
Kazutoshi Komiya e.al.
Onco Targets Ther.2016 Oct 27;9:6663-6668.
DOI: 10.2147/OTT.S114492

10 カクテル抗体

11 カクテル抗体

12 カクテル抗体

13 バイオバンク

14 バイオバンク

15 デジタルパソロジー

Difference of Morphology and Immunophenotype between Centraland Peripheral Squamous Cell Carcinomas of the Lung.
Tomayoshi Hayashi et.al.
Biomed Res Int. 2013;2013:157838.
DOI: 10.1155/2013/157838
How Sensitive Are Epidermal Growth Factor Receptor–Tyrosine
Kinase Inhibitors for Squamous Cell Carcinoma of the Lung
Harboring EGFR Gene–Sensitive Mutations?
Akito Hata et.al.
J Thorac Oncol. 2013 Jan;8(1):89-95.
DOI: 10.1097/JTO.0b013e31827690b5
A case of napsin A-positive metastatic lung cancer originating fromthe colon.
Tomokazu Ito et.al.
Surg Case Rep. 2017 Nov 9;3(1):114.
DOI: 10.1186/s40792-017-0389-9
Development of Kras mutant lung adenocarcinoma in mice withknockout of the airway lineage‐specific gene Gprc5a.
Junya Fujimoto et.al.
Int J Cancer. 2017 Oct 15;141(8):1589-1599
DOI:10.1002/ijc.30851
Multi-region exome sequencing reveals genomic evolution frompreneoplasia to lung adenocarcinoma.
Xin Hu et.al
Nat Commun. 2019 Jul 5;10(1):2978
DOI:10.1038/s41467-019-10877-8
A narrative review of digital pathology and artificial intelligence:focusing on lung cancer.
Taro Sakamoto et.al.
Transl Lung Cancer Res2020
DOI:10.21037/tlcr-20-591※リンクを張ることが可能なものには、DOIにリンクを張ってあります。